A Multicenter, Randomized, Vehicle-Controlled, Efficacy and Safety Study of CD2027 3 microg/g Oily Spray Applied Twice Daily for 8 Weeks in Subjects With Plaque-Type Psoriasis.
Phase of Trial: Phase II
Latest Information Update: 10 Jan 2012
At a glance
- Drugs Calcitriol (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Galderma
- 27 Oct 2009 New trial record.